Neurofibromatosis type i: Points to be considered by general pediatricians

Citations

SCOPUS

21

초록

Neurofibromatosis type 1 (NF1), a prevalent genetic disease that is transmitted in an autosomal dominant manner, is characterized by multiple cutaneous café-au-lait spots and neurofibromas as well as various degrees of neurological, skeletal, and neoplastic manifestations. The clinical features of NF1 increase in frequency with age, while the clinical diagnosis can remain undetermined in some pediatric patients. Importantly, affected patients are at risk for developing tumors of the central and peripheral nervous system. Therefore, adequate counseling for genetic testing, age-appropriate surveillance, and management are important. This review suggests several issues that should be considered to help general pediatricians provide adequate clinical care and genetic counseling to patients with NF1 and their families. © 2021 by The Korean Pediatric Society.

키워드

Diagnosis; Neurofibromatosis type 1; NF1; Surveillance; Treatment; imatinib; luteinizing hormone; mitogen activated protein kinase 1; mitogen activated protein kinase 3; neurofibromin; peginterferon; pirfenidone; tipifarnib; vitamin D; astrocytoma; autism; autosomal dominant inheritance; child; disease surveillance; dysplasia; exophthalmos; female; gene mutation; genetic analysis; genetic counseling; genetic disorder; genetic screening; genotype; glioma; histology; human; multiple sclerosis; neurofibroma; neurofibromatosis type 1; neuropsychological test; nuclear magnetic resonance imaging; pediatric patient; pediatrician; peripheral nervous system; phenotype; polymerase chain reaction; prevalence; pseudarthrosis; quality of life; Review; risk assessment; seizure; signal transduction; skin; strabismus; tumor volume
제목
Neurofibromatosis type i: Points to be considered by general pediatricians
저자
Kang, E.; Yoon, H.M.; Lee, B.H.
DOI
10.3345/cep.2020.00871
발행일
2021-04
유형
Review
저널명
Clinical and Experimental Pediatrics
권
64
호
4
페이지
149 ~ 156